DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Exelon (Rivastigmine Tartrate) - News

 
 



News related to Exelon (Rivastigmine) and/or conditions it is approved for

Anavex announces positive dose-response data for ANAVEX 2-73 in Alzheimer's disease patients
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.01.12]
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer's disease, other...

Neurotrope initiates Phase 2b study of bryostatin for treatment of Alzheimer's disease
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.01.11]
Neurotrope, Inc. (NTRP) has announced the initiation of a Phase 2b clinical trial of lead candidate Bryostatin 1 for the treatment of Alzheimer's Disease.

Alzheimer's Disease
Source: MedicineNet Advance Medical Directives Specialty [2015.09.17]
Title: Alzheimer's Disease
Category: Diseases and Conditions
Created: 8/26/2008 12:00:00 AM
Last Editorial Review: 9/17/2015 12:00:00 AM

7 Alzheimer's Disease Stages and Symptoms
Source: MedicineNet Swallowing Specialty [2015.09.04]
Title: 7 Alzheimer's Disease Stages and Symptoms
Category: Diseases and Conditions
Created: 7/30/2014 12:00:00 AM
Last Editorial Review: 9/4/2015 12:00:00 AM

Alzheimer's Disease - Test Your Medical IQ
Source: MedicineNet Advance Medical Directives Specialty [2015.03.23]
Title: Alzheimer's Disease - Test Your Medical IQ
Category: MedicineNet Quiz
Created: 2/2/2012 5:35:00 PM
Last Editorial Review: 3/23/2015 4:01:03 PM

FDA Approves Combo Pill for Alzheimer's Disease
Source: MedicineNet donepezil Specialty [2014.12.29]
Title: FDA Approves Combo Pill for Alzheimer's Disease
Category: Health News
Created: 12/29/2014 12:00:00 AM
Last Editorial Review: 12/29/2014 12:00:00 AM

Alzheimer's Disease Patient Caregiver Guide
Source: MedicineNet memantine Specialty [2014.03.26]
Title: Alzheimer's Disease Patient Caregiver Guide
Category: Diseases and Conditions
Created: 8/26/2008 12:00:00 AM
Last Editorial Review: 3/26/2014 12:00:00 AM

ARICEPT (Donepezil) effective for severe Alzheimer's disease
Source: The Doctors Lounge - Neurology
Donepezil reverses some aspects of cognitive deterioration seen in severe Alzheimer's disease.

Gene study points towards therapies for common brain disorders
Source: Genetics News From Medical News Today [2016.01.28]
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities.

No Worries! CAD Risk Disclosure OK at Alzheimer's Genotyping
Source: theheart.org | Medscape Cardiology Headlines [2016.01.27]
It's "psychologically safe" to divulge extra information about risk for preventable diseases when genotyping for Alzheimer's disease; but it's premature to recommend APOE4 screening, experts say.
Medscape Medical News

Brain BDNF Expression May Explain Cognitive Reserve
Source: Medscape NeurologyHeadlines [2016.01.27]
Boosting BDNF gene expression might be a good therapeutic strategy to prevent Alzheimer's disease, researchers speculate.
Medscape Medical News

Alzheimer-type brain pathology after transplantation of dura mater
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2016.01.27]
Up to now Alzheimer's disease has not been recognised as transmissible. Now researchers at the University of Zurich and the Medical University Vienna demonstrated Alzheimer-type pathology in brains...

Exposure to environmental toxin may lead to Alzheimer's
Source: Water - Air Quality / Agriculture News From Medical News Today [2016.01.20]
Researchers found that monkeys fed fruits containing a blue-green algae known as BMAA developed brain plaques and tangles - a hallmark of Alzheimer's disease.

Common therapy for prostate cancer may raise risk of Alzheimer's
Source: Prostate / Prostate Cancer News From Medical News Today [2015.12.08]
A study of patient records suggests ADT - a testosterone-lowering therapy - for prostate cancer may raise the risk for Alzheimer's disease and says further research is needed.

Alzheimer's may be a collection of diseases that should be treated separately
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2015.11.05]
It is essential to carefully characterize and classify the mechanisms that underlie Alzheimer's disease, in order to allow for the development of novel therapies that can be prescribed according to...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015